Clinical Trials List
2025-08-31 - 2028-08-31
Recruiting3
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Shang-Fu Hsu Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 楊善堯 Division of Thoracic Medicine
- Chia-Lun Chang Division of Thoracic Medicine
- Chih-Hsin Lee Division of Thoracic Medicine
- Tzeon-jye Chiou Division of Thoracic Medicine
- Jer-Hwa Chang Division of Thoracic Medicine
- 石智元 Division of Thoracic Medicine
- 江振源 Division of Thoracic Medicine
- Yu-Tien Tzeng Division of Thoracic Medicine
- Tzu-Yao Liao Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
7 participants
-
Global
284 participants
